Science Explorer Interactive view Map
Company · Utrecht · Netherlands

Polpharma Biologics (Netherlands)

polpharmabiologics.comROR OpenAlex
World rank, all time
#12,558
of 42,892
Rank in Netherlands
#154
of 464
Research works
125
▼ 31% vs 2013–17
Citations
6.2k
49.5 per fractional work
Top-10% rate
18.1%
record average 16.5%
Open access
60%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.19× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.77× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 26.03× its world share, 2 worksImmunology and Micro…Neuroscience: 0.89× its world share, 0 worksNeuroscienceChemistry: 0.57× its world share, 0 worksChemistryEngineering: 0.45× its world share, 0 worksEngineeringMaterials Science: 0.77× its world share, 0 worksMaterials ScienceMathematics: 0.46× its world share, 0 worksMathematicsHealth Professions: 0.29× its world share, 0 worksHealth ProfessionsMedicine: 2.23× its world share, 3 worksMedicineNursing: 2.20× its world share, 0 worksNursingBusiness, Management and Accounting: 0.24× its world share, 0 worksBusiness, Management…Social Sciences: 0.44× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 26.0×. Every wedge is a field page.

Who are the top researchers at Polpharma Biologics (Netherlands)?

Ranked on the composite score, Louis Boon lead among researchers whose main affiliation is Polpharma Biologics (Netherlands).

  1. 1 Louis Boon Netherlands · #316,852 worldwide 198 citations · 68 works
All ranked researchers at Polpharma Biologics (Netherlands)

Which keywords describe research at Polpharma Biologics (Netherlands)?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Immunity, Cancer Immunotherapy, Innate Immunity, Antigen Presentation, Dendritic Cells, Epidemiology and Tumor Antigen.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation16▲ 5.5×38 topics
  2. Epidemiology15▲ 2.9×47 topics
  3. Immunity13▲ 31×10 topics
  4. Cancer Immunotherapy11▲ 64×3 topics
  5. Innate Immunity10▲ 23×7 topics
  6. Antigen Presentation9▲ 73×2 topics
  7. Dendritic Cells9▲ 64×2 topics
  8. Tumor Antigen9▲ 84×1 topic
  9. Vaccine Adjuvants9▲ 84×1 topic
  10. Autoimmunity8▲ 33×4 topics
  11. NK Cell Recognition8▲ 65×1 topic
  12. Natural Killer Cells8▲ 65×1 topic
  13. TGF-ß8▲ 36×3 topics
  14. Cancer7▲ 3.9×17 topics
  15. CD4+CD25+7▲ 71×1 topic
  16. Foxp37▲ 71×1 topic
  17. Diagnosis5▲ 4.2×16 topics
  18. Immunotherapy5▲ 5.7×8 topics
  19. Monoclonal Antibodies4▲ 24×3 topics
  20. Treatment4▲ 2.6×12 topics
  21. Management4▲ 4.1×9 topics
  22. Tumor Microenvironment4▲ 9.1×7 topics
  23. Regulatory T Cells4▲ 28×4 topics
  24. Therapeutic Antibodies4▲ 23×2 topics
  25. Glycosylation4▲ 13×3 topics
  26. Immune Response3▲ 4.4×14 topics
  27. Angiogenesis3▲ 6.4×10 topics
  28. Children3▲ 10×2 topics
  29. Cytokines3▲ 9.6×5 topics
  30. Activation3▲ 66×1 topic
  31. Inflammatory Diseases3▲ 20×4 topics
  32. Macrophage3▲ 41×1 topic
  33. Tumor Regression3▲ 27×2 topics
  34. Asthma3▲ 17×2 topics
  35. Lymphoma3▲ 14×2 topics
  36. Immune Checkpoint Blockade2▲ 36×1 topic
  37. PD-1 and PD-L12▲ 36×1 topic
  38. Antibody Engineering2▲ 19×1 topic
  39. CAR T Cells2▲ 45×1 topic
  40. Chimeric Antigen Receptor2▲ 45×1 topic

Which research topics does Polpharma Biologics (Netherlands) publish most on?

By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, Immune Cell Function and Interaction, Immunotherapy and Immune Responses and Orthopaedic implants and arthroplasty.

Monoclonal and Polyclona…1Monoclonal and Polyclonal Antibodies Research: 1 fractional worksImmune Cell Function and Interaction: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional worksOrthopaedic implants and arthroplasty: 0 fractional worksAutoimmune Bullous Skin Diseases: 0 fractional worksNeutrophil, Myeloperoxidase and Oxidative Mechanisms: 0 fractional worksImmune cells in cancer0Immune cells in cancer: 0 fractional worksProtein purification and stability: 0 fractional worksDiabetes and associated disorders: 0 fractional worksSocial and Political Issues: 0 fractional works
Radiology, Nuclear Medicine and ImagingImmunologySurgeryPathology and Forensic Medicine3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  2. 2 Immune Cell Function and Interaction Immunology 0 works
  3. 3 Immunotherapy and Immune Responses Immunology 0 works
  4. 4 Orthopaedic implants and arthroplasty Surgery 0 works
  5. 5 Autoimmune Bullous Skin Diseases Pathology and Forensic Medicine 0 works
  6. 6 Neutrophil, Myeloperoxidase and Oxidative Mechanisms Immunology 0 works
  7. 7 Immune cells in cancer Immunology 0 works
  8. 8 Protein purification and stability Molecular Biology 0 works
  9. 9 Diabetes and associated disorders Genetics 0 works
  10. 10 Social and Political Issues Sociology and Political Science 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available59.8%not open40.2%

World: 28% of research is openly available.

with international co-authors54.0%domestic only46.0%

World: 19% is written across borders.

How has Polpharma Biologics (Netherlands)'s research output changed?

Output in 2018–2022 was 31% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Utrecht

All research institutions in Utrecht

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.